Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving well-being and health in heart failure patients

Official title: A Novel Behavioral Intervention to Promote Adherence in Heart Failure

Run by Massachusetts General Hospital · NCT04829617 · Data updated 2026-11-12

This study is testing a new phone-based program that combines positive psychology and motivational support to see if it can help heart failure patients improve their health and well-being over six months.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment280 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedNovember 29, 2021
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedApril 14, 2026
Trial IDNCT04829617 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with NYHA class I, II, or III heart failure who struggle with adherence to health behaviors.

Probably not a fit

Patients with cognitive deficits, severe medical conditions, or those currently engaged in similar interventions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a 12-week phone-delivered Positive Psychology-Motivational Interviewing (PP-MI) intervention, supplemented by health behavior text messages over 24 weeks, for patients with New York Heart Association class I-III heart failure. The goal is to evaluate the intervention's effectiveness on health behavior adherence, psychological outcomes, and cardiovascular health markers. Participants will engage in two visits for assessments and monitoring, with a focus on improving quality of life and reducing hospitalizations.

Why it matters

Potential benefit: If successful, this intervention could enhance health behaviors and overall well-being in heart failure patients, potentially leading to better health outcomes.

How similar studies have gone: Other studies have shown promise in using motivational interviewing and positive psychology approaches for improving health outcomes, suggesting this intervention could be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients with NYHA class I, II, or III HF.
* Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS) items regarding diet/exercise/medications.

Exclusion Criteria:

* Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test.
* Medical conditions likely to lead to death within 6 months.
* Inability to participate in physical activity due to another medical condition (e.g., arthritis).
* Inability to read, write, or speak in English.
* Current participation in another intervention or program that has been designed to promote well-being or health behavior adherence.

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Christopher M Celano, MD — Massachusetts General Hospital
  • Study coordinator: Christohper M Celano, MD
  • Email: ccelano@partners.org
  • Phone: 617-726-6485

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.